The Biologic Activities of Peptidoglycan in ExperimentalHaemophilus influenzaeMeningitis

Abstract
While gram-positive bacterial cell walls are known to incite inflammation, the contribution of gram-negative peptidoglycan to disease has not been characterized. The ability of cell wall, purified peptidoglycan, and soluble peptidoglycan subcomponents from Haemophilus influenzae to provoke inflammation was determined in a rabbit model of meningitis, Haemophilus peptidoglycan, with or without associated proteins, produced brain edema at ⩾O.l µg/mL of cerebrospinal fluid (CSF); leukocytosis and protein accumulation in CSF occurred only at ⩾1O.O µg/mL of CSF. Solubilized peptidoglycan was to-fold more active than intact cell wall. The bioactivity of peptidoglycan from ampicillin-resistant H. influenzae was at least two fold greater than that of ampicillin-sensitive strains. Consistent with these pathologic effects of purified peptidoglycan, ampicillin-induced bacteriallysates in which endotoxin was neutralized induced brain edema and protein influx but little leukocytosis. Thus, peptidoglycan seems to contribute to the pathology of gram-negative meningitis, particularly brain edema.